Literature DB >> 20935493

Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.

Susana Llanos1, Manuel Serrano.   

Abstract

Perturbation of ribosomal biogenesis has recently emerged as a relevant p53-activating pathway. This pathway can be initiated by depletion of certain ribosomal proteins, which is followed by the binding and inhibition of MDM2 by a different subset of ribosomal proteins that includes L11. Here, we report that depletion of L37 leads to cell cycle arrest in a L11- and p53-dependent manner. DNA damage can initiate ribosomal stress, although little is known about the mechanisms involved. We have found that some genotoxic insults, namely, UV light and cisplatin, lead to proteasomal degradation of L37 in the nucleoplasm and to the ensuing L11-dependent stabilization of p53. Moreover, ectopic L37 overexpression can attenuate the DNA damage response mediated by p53. These results support the concept that DNA damage-induced proteasomal degradation of L37 constitutes a mechanistic link between DNA damage and the ribosomal stress pathway, and is a relevant contributing signaling pathway for the activation of p53 in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935493      PMCID: PMC3615335          DOI: 10.4161/cc.9.19.13299

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  36 in total

1.  Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.

Authors:  Xiao-Xin Sun; Yue-Gang Wang; Dimitris P Xirodimas; Mu-Shui Dai
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

2.  Ribosomal protein S27L is a direct p53 target that regulates apoptosis.

Authors:  H He; Y Sun
Journal:  Oncogene       Date:  2006-10-23       Impact factor: 9.867

Review 3.  Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway.

Authors:  C Deisenroth; Y Zhang
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

4.  Regulation of nucleolar signalling to p53 through NEDDylation of L11.

Authors:  Anders Sundqvist; Geng Liu; Antonis Mirsaliotis; Dimitris P Xirodimas
Journal:  EMBO Rep       Date:  2009-08-28       Impact factor: 8.807

5.  Chemotherapeutic drugs inhibit ribosome biogenesis at various levels.

Authors:  Kaspar Burger; Bastian Mühl; Thomas Harasim; Michaela Rohrmoser; Anastassia Malamoussi; Mathias Orban; Markus Kellner; Anita Gruber-Eber; Elisabeth Kremmer; Michael Hölzel; Dirk Eick
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

Review 6.  p53--a Jack of all trades but master of none.

Authors:  Melissa R Junttila; Gerard I Evan
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

7.  Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation.

Authors:  Mikael S Lindström; Monica Nistér
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

Review 8.  Mdm2-mediated ubiquitylation: p53 and beyond.

Authors:  J-C Marine; G Lozano
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

Review 9.  Signaling to p53: ribosomal proteins find their way.

Authors:  Yanping Zhang; Hua Lu
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

Review 10.  Tumour suppression by p53: a role for the DNA damage response?

Authors:  David W Meek
Journal:  Nat Rev Cancer       Date:  2009-09-04       Impact factor: 60.716

View more
  31 in total

1.  The RP-p53-Mdm2 pathway: a new link to genetic integrity?

Authors:  Rebeca A Frum; Yanping Zhang
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

2.  Disruption of the ribosomal P complex leads to stress-induced autophagy.

Authors:  Ana Artero-Castro; Mileidys Perez-Alea; Andrea Feliciano; Jose A Leal; Mónica Genestar; Josep Castellvi; Vicente Peg; Santiago Ramón Y Cajal; Matilde E L Lleonart
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

3.  Scission of the p53-MDM2 Loop by Ribosomal Proteins.

Authors:  Xiang Zhou; Jun-Ming Liao; Wen-Juan Liao; Hua Lu
Journal:  Genes Cancer       Date:  2012-03

Review 4.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

5.  CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination.

Authors:  Paolo Latini; Mattia Frontini; Manuela Caputo; Juraj Gregan; Lubos Cipak; Silvia Filippi; Vivek Kumar; Renier Vélez-Cruz; Miria Stefanini; Luca Proietti-De-Santis
Journal:  Cell Cycle       Date:  2011-11-01       Impact factor: 4.534

6.  Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.

Authors:  X Zhou; Q Hao; J Liao; Q Zhang; H Lu
Journal:  Oncogene       Date:  2012-03-05       Impact factor: 9.867

Review 7.  Ribosomal proteins: functions beyond the ribosome.

Authors:  Xiang Zhou; Wen-Juan Liao; Jun-Ming Liao; Peng Liao; Hua Lu
Journal:  J Mol Cell Biol       Date:  2015-03-03       Impact factor: 6.216

8.  Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.

Authors:  Qi Zhang; Hui Xiao; Sergio C Chai; Quyen Q Hoang; Hua Lu
Journal:  J Biol Chem       Date:  2011-09-08       Impact factor: 5.157

9.  Growth inhibitory effects of large subunit ribosomal proteins in melanoma.

Authors:  Gregory R Kardos; Mu-Shui Dai; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2014-06-16       Impact factor: 4.693

Review 10.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.